Moderna

We announced today that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has granted authorization for our respiratory syncytial virus (RSV) vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults 60 years of age and older. Read more: https://lnkd.in/eTrVFkzV.

For Michelle Patel, joining Moderna was about taking the next step in her #career and finding the right place to drive meaningful change in medicine. It takes urgency, focus and the right team to transform #innovation into life-changing treatments. 💡 “I wanted to be at the precipice of changing the way we think about treating cancers, rare diseases and beyond,” Michelle shares. Read more about Michelle’s role and the mission that is clear to her at Moderna: advance science, embrace risk and push medicine forward for patients who need it most: https://lnkd.in/epWxceDd.

Viruses are not technically alive. Sounds surreal, right? But how do they manage to replicate and spread despite lacking the machinery to survive on their own? See how it all works in this video, where we uncover the fascinating strategies viruses use to thrive. For a deeper look, head to Module 1 on our free mRNAs as Medicines Coursera course to learn more about viruses: https://lnkd.in/ezu8Wwmc #mRNA101 #mRNAScience #MicroLearning #InnovationInMedicine #ScienceSimplified #FutureOfHealthcare

🚀 Welcome, 1st Half 2025 Co-op Cohort! 🚀 We’re excited to welcome 60 talented students from 38 universities into our Co-op Program! Over the next five months, they will gain hands-on experience and contribute to impactful projects across Moderna. Their journey kicked off with insightful speaker sessions covering our commitment to health equity, the science behind our platform and the impact of our Employee Resource Groups. We can’t wait to see the energy, ideas and innovation they bring!🎉 #ModernaCoop #EarlyCareer #CampusRecruiting

Staying informed about the latest #COVID19 vaccine recommendations is crucial for protecting yourself, especially if you're an older adult or have a weakened immune system. The U.S. CDC recommends that everyone 65 years and older, along with those who are moderately or severely immunocompromised, receive a second dose of the updated 2024-2025 COVID-19 vaccine six months after your first. Read more from Francesca Ceddia our Chief Medical Affairs Officer on the importance of this second dose: https://lnkd.in/ecB57yB3

Earlier today, we reported financial results and provided business updates for the fourth quarter and fiscal year 2024. Members of our executive team sat down in latest episode of our #IRInsights series to provide more insight into our financial performance and upcoming late-stage pipeline milestones. https://lnkd.in/eNKkVR6B

Today, we reported financial results and provided business updates for the fourth quarter and fiscal year 2024. Read more: https://lnkd.in/emzf59kc

Introducing mRNAs as Medicines, a micro-learning video series that explores the fascinating world of #mRNA science—how it works, why it’s groundbreaking and how it has the potential to shape a new era of medicine. Think of it as your backstage pass to understanding everything from protein science to vaccine innovations. For a deeper look, head to our free Coursera course or keep an eye out for the next episode in our series. Learn more: https://lnkd.in/ezu8Wwmc #mRNA101 #mRNAScience #MicroLearning #InnovationInMedicine #ScienceSimplified #FutureOfHealthcare

This #BlackHistoryMonth, we sat down with Jameka Hill, our Head of Clinical Trial Health Equity, to discuss why #inclusivity in research is a scientific imperative. From breaking barriers to building trust, Jameka shares how Moderna is working to help ensure that the medicines of tomorrow reflect the broader population today. Read the full Q&A here: https://lnkd.in/ewaMgdeY

Today, on #InternationalDayofWomenandGirlsinScience, we’re proud to highlight the incredible work of Joanna Prieto, founder of Geek Girls LatAm, a nonprofit dedicated to empowering women and girls in Latin America to thrive in STEM. Through our partnership with Ashoka, the Moderna Charitable Foundation is supporting visionary leaders like Joanna, who are breaking barriers, fostering innovation and ensuring more young women have the opportunity to lead in science and technology. In a conversation with Clara Fernandez de Castro, our Sr. Director of ESG Strategy , Joanna shared her inspiring journey—from receiving her first computer at age nine, to pioneering remote learning and building a movement that champions women in #STEM. 💡 Read the full interview to learn more: https://lnkd.in/dC9Axwen